MedTrace Logo

RibFix Blu Thoracic Fixation System Versus Non-surgical Treatment in Non-flail Chest Rib Fractures

NCT05146986 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2024-03-07

No results posted yet for this study

Summary

This is a prospective, multi-center, observational, cohort study involving skilled cardiothoracic surgeons who are experienced in implanting the treatment of non-flail chest rib fractures and the use of RibFix Blu Thoracic Fixation System.

Conditions

  • Rib; Fracture

Interventions

DEVICE

Non surgical and Surgical

For non-surgical group, patients will receive non-surgical treatment (analgesia and symptomatic management treatment). For surgical group, patients will receive surgical treatment using RibFix Blu Thoracic Fixation System.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Silvana Marasco, Professor · The Alfred

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-02
Primary Completion
2025-12-30
Completion
2026-12-30
FDA Device
Yes

Countries

  • Australia
  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05146986 on ClinicalTrials.gov